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1. Introduction
As we stated in a previous book chapter titled “Somatic conditions intrinsic to anxiety disor‐
ders” [1], Johann Christian August Heinroth (1773-1843) was the person who introduced for
the first time the term ‘psychosomatic’ into medical literature. The psychosomatic approach
offers an overall or holistic “body and mind” perception that can be often useful for preven‐
tion purposes. Unfortunately, up to the present day Heinroth’s contributions to the develop‐
ment of medicine and psychosomatics have been little acknowledged. Possibly, the current
medical tendency towards specialisation makes it difficult to embody such paradigms in
current psychiatric and medical nosology.
In this sense, the group of anxiety disorders have been included alternatively among the so‐
matic and among the mental conditions when, in fact, anxiety disorders include both strong
somatic and mental dimensions which need to be dealt with. The study of somatic condi‐
tions linked to anxiety disorders provide insights into the biology of these mental disorders
that may result in a greater understanding of its aetiology, treatment, and prevention. In this
second chapter we shall review, up to the last findings, the comorbidity of anxiety and phys‐
ical disorders linked to joint hypermobility syndrome (JHS). This relationship is one of the
strongest available evidences of the somatic components of anxiety disorders.
2. Anxiety disorders do relate to some somatic conditions
Patients with anxiety disorders often complain of somatic features, especially cardiac (tachy‐
cardia, chest pain), gastrointestinal (epigastric pain), and neurological complaints (head‐
aches, dizziness, or presyncope), in emergencies and primary services [2-4]. This clinical
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phenomenon helped to deepen into the study of differential diagnoses: are they symptoms
of the primary anxiety disorder or are they symptoms of a comorbid physical illness? [5-7].
Besides, more recent research suggests a strong association between anxiety disorders and
somatic conditions, although some authors emphasize the huge amount of published re‐
search about somatic conditions and depression in contrast to the few studies about the
same relationship with anxiety disorders [8-10]. Furthermore, results from the National Co‐
morbidity Survey-Replication (NCS-R) showed that various anxiety disorders had equal or
greater association than depression with four chronic physical disorders (hypertension, ar‐
thritis, asthma, and ulcers) [11].
The more recent review articles about this relationship are organized according to medi‐
cal  illness  specifically  associated to anxiety disorders  in several  descriptive and analytic
studies  with clinical  samples [2,3,9,12,13].  These reviews often include the following so‐
matic  conditions:  irritable  bowel  syndrome,  asthma,  cardiovascular  disease,  cancer,
chronic pain, vestibular and thyroid dysfunction, chronic obstructive pulmonary disease,
and mitral valve prolapse. Some of the main general conclusions of these reviews are the
following:  1)  emerging  evidence  about  the  bi-directional  relationship  between  anxiety
disorders and medical  illness suggests that  they may be as important as depression [9];
2) such associations provide important clues for understanding the neurobiology of anxi‐
ety disorders [2];  and 3)  such associations are greater  for  panic  disorder [12,3],  worsen‐
ing its identification, presentation and treatment [13].
Along this way, there are four studies relying on clinical samples that have shown high‐
er  rates  of  somatic  conditions among patients  with anxiety disorders  (table  1).  The first
one was published in 1994.  Rogers et  al.  examined the prevalence and characteristics of
medical illness in 711 patients with present or past index anxiety disorders [14]. Patients
were  assessed  using  structured  diagnostic  interviews  and the  Medical  History  Form II.
The rates of medical illness for all subjects were later compared with data extracted from
an epidemiological  sample.  Results  showed that  patients  with  panic  disorder  had more
reported medical problems than the general population, in particular, more ulcer disease,
angina, and thyroid disease.
In 2003, Härter et al. studied the associations between anxiety disorders and medical illness‐
es in a total of 262 probands (169 cases with an anxiety disorder and 93 controls with no evi‐
dence of an anxiety disorder according to DSM-III-R criteria) [8]. Diagnoses were obtained
based on direct interview (SADS) or family history information, and lifetime history of nu‐
merous medical illnesses was obtained. Results showed that patients with a lifetime anxiety
disorder reported higher rates of several medical illnesses than did persons without anxiety.
After controlling for the effects of gender, comorbid substance abuse/dependence and/or de‐
pression, significant associations were found between anxiety disorders and cardiac disor‐
ders (OR = 4.6), hypertension (OR = 2.4), gastrointestinal problems (OR = 2.4), genitourinary
disorders (OR = 3.5), and migraine (OR = 5.0). A similar pattern was observed for probands
with panic or generalized anxiety disorder.
In  2005,  Sareen  et  al.  examined the  relationship  between  anxiety  disorders  and a  wide
range of  physical  conditions  in  a  nationally  representative  sample.  Data  came from the
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National Comorbidity Survey (N=5,877). Physical disorders were assessed based on a list
of several conditions shown to respondents.  Results showed that anxiety disorders were
positively  associated  with  physical  conditions  even  after  adjusting  for  mood  disorders,
substance-use disorders, and sociodemographics. Among specific anxiety disorders, panic
disorder and agoraphobia were more likely to be associated with cardiovascular disease
and bone and joint diseases [10].
In 2008, in a case-control study carried out by our group [15] using retrospective data ex‐
tracted from clinical records, patients with anxiety disorders showed higher risk of medical
illnesses than patients without anxiety disorders. The aim of the study was to investigate the
comorbidity between anxiety disorders and somatic conditions in three groups: patients
with anxiety disorders (n=130) including panic disorder with/without agoraphobia and ago‐
raphobia without panic attacks, patients from a primary care unit without any psychiatric
disorder (n=150), and patients from a psychiatric service without anxiety disorders (n=130).
Multivariate statistical logistic regression analysis showed that patients with anxiety disor‐
ders presented 4.2-fold increase in the risk of cephalea, 3.9 of cardiopathy, 3.8 of osteomus‐
cular disorder and 2-fold increase in the risk of digestive diseases.
Type N Data assessment Main associations
Rogers et al. 1994
[14] D 711
Structured diagnostic
interview Ulcer disease, angina & thyroid disease
Härter et al. 2003
[8] CC 262
Direct interview & medical
records
Cardiac disorders, hypertension, digestive
problems, genitourinary disorders &
migraine
Sareen et al. 2005
[10] E 5877 List of several conditions
Cardiac disorders & bone and joint
diseases
Pascual et al. 2008
[15] CC 410 Medical records
Cephalea, cardiac disorders, bone and
joint diseases & digestive problems
Table 1. Relationship between medical conditions and anxiety disorders. Basic features of studies reviewed. D,
descriptive study; CC, case–control study; E, epidemiological study.
3. Measuring medical conditions in anxiety patients
Despite the significant prognostic and therapeutic implications derived from the comorbidi‐
ty between mental disorders and medical conditions, there is a lack of measuring instru‐
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ments designed to quantify the physical health and disease in psychiatric population.
Obviously, the use of these instruments in clinical settings is virtually absent. In this sense,
our team developed, for over a decade, the Spanish version of the Cumulative Illness Rating
Scale [16] designed for the assessment of medical conditions in general. The issues chosen
for this instrument to assess illness severity were related to life-risk, functional disability
and the need for treatment. Our group is now actively working on a variation of this scale,
specially designed to detect medical conditions, including some functional diseases, on anxi‐
ety and depressive patients. Some of these functional diseases assessed are atopy and aller‐
gies, tensional headache and migraine, fibromyalgia, irritable bowel syndrome, dysfagia
and dyspepsia, interstitial cystitis, sexual dysfunction, temporo-mandibular joint disorder,
and chronic fatigue syndrome.
There are various hypotheses on how anxiety disorders and medical conditions may be re‐
lated [14]. Medical illness may sometimes directly trigger the development of anxiety symp‐
toms (e.g., cardiomyopathy or anxiety as a psychological reaction towards an illness), or
mimic anxiety symptoms (e.g. pheochromocytoma). Conversely, anxiety disorders may
sometimes directly trigger the development of somatic symptoms (e.g., angina in cardiovas‐
cular disease), mimic symptoms of a medical illness (leading to high costly procedures or
inadequate treatment), or may contribute to the onset or exacerbation of certain somatic con‐
ditions (e.g., hypertension or gastric ulcer).
However, there is evidence that some medical conditions that are often comorbid with anxi‐
ety disorders could share a common genetic etiology [17-19]. For example, Talati et al. stud‐
ied probands with diagnosis and family history of panic disorder (n=219), social anxiety
disorder (n=199), or both (n=173), and 102 control subjects with no personal/family history of
anxiety. Subjects were blindly interviewed with a diagnostic instrument and medical history
was obtained via medical checklist and the family history screen [20]. They found that panic
or social anxiety patients and their first-degree relatives were more likely to have interstitial
cystitis, mitral valve prolapse and headaches, and this was hypothesized to be linked to a
common genetic susceptibility. According to this hypothesis, several studies have shown a
noticeable association between anxiety disorders (particularly panic/phobic cluster) and the
joint hypermobility syndrome (JHS) [21-23]. This association has allowed a wider “body and
mind” comprehension of anxiety disorders and has provided new clues in order to measure
medical conditions in these patients.
4. Anxiety disorders and the role of collagen tissue
JHS is an inherited connective tissue disorder associated with a generalized collagen laxity
and characterized by an increase of active or passive joint mobility. The condition was not
described for the first time until fifty years ago by Rotés, when it was properly identified
and associated to pathology of the musculoskeletal system [24]. In 1973, after an epidemio‐
logical study by Beighton et al., the syndrome gained general interest in the rheumatological
field and began to be studied in a broader way, as a separate entity [25] (see Fig.1).
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Figure 1. Joint Hypermobility criteria [25]1.Passive apposition of the thumbs to the flexor aspects of the forearm (one
point for each thumb). 2. Hyperextension of the knee beyond 10º (one point for each knee). 3. Passive dorsiflexion of
the little fingers beyond 90º (one point for each hand). 4. Hyperextension of the elbows beyond 10º (one point for
each elbow). 5. Forward flexion of the trunk with knees fully extended so that the palms of the hands rest flat on the
floor (one point).
In 1992, the Hospital del Mar criteria (table 2) compiled all the items included in the most
clinically used criteria. This new scale showed consistent indicators of reliability, internal
consistency and predictive validity, and provided evidence for using different scores ac‐
cording to age and gender [26].
Upper extremities
Passive apposition of the thumb to the flexor aspect of the forearm at a distance of less than 21 mm.
The passive dorsiflexion of the fifth finger is 90º or more.
The active hyperextension of the elbow is 10º or more.
External rotation of the shoulder up to more than 85º.
Lower extremities. Supine position
The passive hip abduction can be taken to an angle of 85º or more.
Hypermobility of the rotula.
Hypermobility of the ankle and foot.
Dorsal flexion of the toe of 90º or more.
Lower extremities. Prone position
Hyperflexion of the knee.
Ecchymoses.
Table 2. Hospital del Mar criteria for JHS [26]. Male patients scoring 4 or more are considered cases; female patients
are considered cases with scores 5 or over.
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JHS has an estimated prevalence in the general population ranging between 10% – 15%, it is
more frequent among females (3:1) and is one of the hereditary disorders of the connective
tissue, which include other conditions such as Ehlers-Danlos syndrome, Marfan syndrome
and ostogenesisimperfecta [27]. Clinical features in JHS can be articular or extra-articular
and are always related to the connective tissue. Among the best known articular features of
JHS are arthralgia, lumbalgia, soft-tissue rheumatism (e.g., epicondilytis, tenosynovitis, bur‐
sitis), recurrent dislocations, childhood scoliosis, or rheumatoid arthritis [28,29]. Among the
best-known extra-articular features of JHS are hernias, varicose veins, “easy bruising”, ke‐
loids, uterine or rectal prolapse, spontaneous pneumothorax, fibromyalgia, dysautonomia
and some other conditions also linked to panic disorder as asthma, mitral valve prolapse,
thyroid dysfunction or irritable bowel syndrome [29,30]. Therefore, most of the conditions
linked to anxiety disorders can be explained as clinical features of JHS. Unfortunately, the
relationship between anxiety disorders and JHS is often neglected.
The clinical relationship between anxiety disorders and JHS was found 50 years ago. In 1957, the
rheumatologist J. RotésQuerol pointed out for the first time the remarkable degree of nervous
tension suffered by patients with hypermobility [24]. To a certain extent, there are some indirect
references about the relationship between “hypotonia” and anxiety/phobias in the classical
psychosomatic literature [31]. On the other hand, Carlsson and Rundgren in 1980 [32] found a
higher score in hypermobility among alcoholic patients than among controls. Although not
mentioned, the percentage of anxiety patients among the case group might have been high.
Empirical history of the clinical relationship between anxiety disorders and JHS starts in the
case-control study conducted by our group in 1993, with rheumatologic outpatients affected
by JHS [21]. Diagnoses of panic disorder, agoraphobia and simple phobia were significantly
more frequent among hypermobile patients. There were no significant differences in the di‐
agnoses of generalized anxiety disorder, dysthymia, or major depressive disorder. Around
70% of rheumatological patients with JHS had some kind of anxiety disorder. However, this
only occurred in 22% of controls, a usual figure in chronic patient samples. Cases were 10
times more likely to suffer from anxiety than controls. Specifically, agoraphobia and panic
disorders were, respectively, 5 and 7 times more likely (table 3).
% JHS % Non-JHS Age-Sex Adjust. OddsRatio 95 % C. I.
Any Anxiety D. 69,3 22,0 10.69 4.80-23.81
Panic D. 34.2 6.8 6.96 2.31-20.91
Panic & Agora. 24.6 5.1 6.40 1.82-22.43
Simple Phobia 29.8 8.5 5.77 2.05-16.24
Agoraphobia 37.7 11.9 5.08 2.06-12.49
General.Anx. 10.5 5.1 2.49 0.65-9.45
Major Depress. 14.9 3.4 4.51 0.99-20.56
Dysthymic D. 7.9 5.1 2.15 0.53-8.65
Table 3. Lifetime psychiatric disorders in JHS cases (n=114) and non-JHS controls (n=59) seen at an outpatient
rheumatological unit [21].
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For a subsequent second study, conducted to support this hypermobility-anxiety associa‐
tion, outpatients with new diagnoses of panic disorder and/or agoraphobia were examined,
as well as non-anxious psychiatric and non-psychiatric outpatients as control groups [33].
Results showed that JHS was present in almost 70% of anxiety cases, versus slightly over
10% of controls. This meant that cases with panic disorders and/or agoraphobia were 17
times more likely to suffer from JHS. Conclusions were valid for women [OR=23.7; CI95%
10.6-52.9] (figure 2), but also for men [OR=10.5; CI95% 3.0-36.3] (figure 3).
15.0%
14.7%
77.9%
0% 20% 40% 60% 80% 100%
Non-Psychiatric controls (n= 64)
 Psychiatric controls (n=99)
 Anxiety cases (n=99)
Figure 2. Women frequencies of JHS diagnoses in anxiety cases (n=99), psychiatric (n=99) and non-psychiatric controls
(n=64) [33].
Figure 3. Men frequencies of JHS diagnoses in anxiety cases (n=99), psychiatric (n=99) and non-psychiatric controls
(n=64) [33].
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Later on, it was suggested that this association needed to be studied in the general popula‐
tion. To that end, a two-phase cross-sectional epidemiological study was carried out in a ru‐
ral town in order to establish lifetime risk for anxiety and affective disorders in subjects with
JHS. A sample of 1,300 individuals were examined at baseline and over 500 were subse‐
quently subjected to follow-up in a two-stage epidemiological study. Hypermobile patients
were eight times more likely to suffer from panic disorder (OR 8.2, CI 95% 3.4 to 19.7), eight
times more likely to suffer from social phobia (OR 7.8; CI 95% 2.4 to 24.8) and six times more
likely to suffer from agoraphobia (OR 5.9; CI 95% 3 to 11.7) than non-JHS patients. Results
were valid for both genders. No differences were found for other anxiety disorders or mood
disorders [22].
In the same sample of general population it was also reported that hypermobiles had signifi‐
cantly higher scores in fear and phobia scales, reinforcing the hypothesis that intensity of
fears is greater in subjects with JHS [34]. We assessed fear intensity and frequency using a
modified version of the Fear Survey Schedule (FSS-III). When we compared the groups with
and without joint hypermobility, the mean total scores for both genders were significantly
higher for the hypermobile group (figure 4). These results showed that the association of
JHS and phobic anxiety is sustained for intense fears and might represent a susceptibility
factor for these anxiety conditions.
 
80
85
90
95
100
105
110
115
120
JHS cases
Non-JHS controls
110.7
93.5
Figure 4. Mean total scores of the Fear Survey Schedule (FSS-III) in JHS cases (n=182) and non-JHS controls (n=1,123) [34].
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The same design was replicated in 2011 in a sample of 150 nonclinical students [35]. Severe
fears and daily consumption of cigarettes, alcohol, coffee, and chocolate were compared
with the hypermobility scores. We found significant differences when comparing severe
fears between the groups with and without hypermobility (7.6 vs. 11; p = 0.001). The fre‐
quency of chocolate intake was also significantly higher among subjects with joint hypermo‐
bility (31.2% vs. 51.2%; p = 0.038). There were no significant differences regarding cigarette
(19.5% vs. 19.3%), alcohol (36.6% vs. 34.9%), and coffee (46.3% vs. 35.8%) consumption.
Therefore, these patterns of consumption may be interpreted as self-treatment attempts of
subsyndromal anxiety in hypermobile subjects (figure 5).
 
0%
10%
20%
30%
40%
50%
60%
Cigarettes Alcohol Coffee Chocolate
19,5
36,6
46,3
31,2
19,3
34,9 35,8
51,2*
Non-JHS controls JHS cases
Figure 5. Frequencies of daily consumption of cigarettes, alcohol, coffee, and chocolate in JHS cases (n=41) and non-
JHS controls (n=109) [35]. *p = 0.038
In 2004, our group also assessed a non-clinical sample of subjects working in the same com‐
pany (N=526) [36]. Subjects with JHS had significantly higher scores in STAI trait anxiety [fe‐
male average: 16.5 vs. 11, p<0.001] [male average: 13 vs. 11, p<0.03]. STAI state anxiety
scores were also higher among hypermobile subjects, although not significantly (figure 6).
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Figure 6. STAI trait anxiety scores (range: 0-60) in 203 women with or without joint hypermobility according to all
possible cutoff scores on the Hospital del Mar hypermobility criteria [36].
In 2005, we studied schizophrenic outpatients (N=124) with the hypothesis that anxiety dis‐
orders mediated by JHS were not symptoms, but an independent comorbid entity in schizo‐
phrenic patients [37,38]. Joint Hypermobility was noticeably more likely among panic
disorder/phobia-clustered schizophrenic patients, than among the non-comorbid group (OR
= 9.35; IC = 95% [3.85-22.73]; p<0.0001). The cluster panic disorder/phobia had higher scores
in fear scales and schizophrenia positive symptom scales. We are now performing a voxel-
based morphometric study in order to examine brain structure, comparing magnetic reso‐
nance images of 20 schizophrenic-anxious patients and 20 schizophrenic patients. The
preliminary results indicated gray matter volume differences in the schizophrenic-anxiety
group in the dorsolateral prefrontal cortex related to the interaction between both condi‐
tions. Our findings suggest that the schizophrenic-anxiety group is characterised by specific
neural abnormalities that cannot be explained by the presence of schizophrenia or anxiety,
but by their conjunction, and this might result in a certain symptomatology [39].
After several significant cross-sectional studies we sought to conduct a prospective incidence
analysis that assesses whether JHS could be a risk factor in developing anxiety conditions [23].
The main objective was to determine the cumulative incidence of anxiety disorders in a co‐
hort of young subjects recruited from the general population who had not developed any
type of anxiety condition up to then; consequently we planned a scheduled 15-year follow-
up covering subjects from late adolescence to adulthood. The total population sample was
1,305 subjects, and in order to observe the development of anxiety disorders during the 15-
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year study period, only the lower age segment (at that time subjects aged between 16 and
20) included in the town’s municipal registry was invited to participate. We sought to de‐
scribe the occurrence of new cases of anxiety disorders during the study period, therefore
the exclusion criterion for the study was having already had an anxiety disorder at baseline
examination. At baseline, 158 subjects were screened for participation in the study, and after
the 15-year follow-up the final sample comprised 137 subjects (86.7% retention rate). Results
showed that cumulative incidence of panic/agoraphobia at follow-up was significantly high‐
er for the JHS group (41.4%) than for the control group (1.9%) with relative risk of 22.3 (CI
95% 4.6-108.7), p<0.0001, (NNT 3, CI 95% 2.9-2.3). Incidence of social phobia and simple pho‐
bia was also significantly higher for the JHS group at (RR=6.52; CI 95% 1.7-24.2) p<0.001 and
(RR=3.31; CI 95% 1.1-9.6) p=0.02, respectively (table 4). Moreover, anxiolytic drug use was
nearly fourfold higher among JHS subjects compared to non-JHS.
Recent work from another Spanish group [40] has shown again a high prevalence of JHS
(61.8%) among panic subjects compared with 10.9% in the healthy control group and 9% in
the psychiatric control group. Interestingly these authors found an intermediate figure
among subjects suffering from fibromyalgia (25.4%). A paper from a Turkish group [41], al‐
beit declaring no significant association, also found JHS in 59.5% of panic disorder patients
with mitral valve prolapse, in 42.9% of patients without mitral valve prolapse but also in
52.6% of control subjects. Gülsün et al. [42], studying subjects with thorax deformities, found
that the anxiety level of males with thorax deformity and JHS is higher than males with
thorax deformity without JHS. And finally, Baeza-Velasco [43] also found high prevalence of
social anxiety and joint hypermobility among subjects of high stature.
Total Sample
n = 137
JHS Status
JHS present
n = 29
JHS absent
n = 108 RR 95% CI P
n % n %
Anxiety Disorders
Panic/Agoraphobia 12 41.4 2 1.9 22.3 (4.6 to 108.7) 0.0001***
Social Phobia 7 24.1 4 3.7 6.5 (1.7 to 24.2) 0.001*
Simple Phobia 8 27.6 9 8.3 3.3 (1.1 to 9.6) 0.02*
GAD 7 24.1 9 8.3 2.9 (0.97 to 8.62) 0.14 ns
Other Disorders
Depression/Dysthymia 7 24.1 7 6.48 3.7 (1.2 to 11.7) 0.15 ns
JHS, Joint Hypermobility Syndrome according to Beighton criteria assessed at baseline. GAD, Generalized Anxiety Dis‐
order Statistical significance: * p<0.05, ** p<0.001, *** p<0.0001, ns: non significant
Table 4. Incident cases and relative risk after 15 years of follow-up according to JHS status [23].
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Type Popul. N groups Sex Age JHS ass. Associationtendencies
Bulbena et al.,
1993 [21] CC Spain
114 JHS
59 CTL Matched Matched Beighton
JHS cases: 5 x Aph and
7 x PD
Martin-Santos et
al., 1998 [33] CC Spain
99 PD &APh
99 Psychiatric CTL
64 Medical CTL
Matched Matched Beighton PD cases: 17 x JHS
Benjamin et al.,
2001 [52] CC Israel
101 PD
39 Healthy CTL
35 / 65
64 / 36
39.3 (11)
23.4 (3) Beighton
No statistically
significant relationship
Bulbena et al.,
2004 [22] E Spain 1305 subjects
45.7 /
54.3 43.4 (18.3) Beighton
JHS cases: 6 x Aph, 8 x
SPh and 8 x PD
Gulpek et al.,
2004 [41] CC Turkey
42 PD & MVP
35 PD
38 MVP CTL
Matched Matched Beighton No statisticallysignificant relationship
Bulbena et al.,
2004 [36] D Spain 526 subjects
61.4 /
38.6 25.4 (3) H. Mar
JHS cases: higher
scores in STAI trait
anxiety
Bulbena et al.,
2005 & 2007
[37,38]
D Spain 124 SCHZ 54 / 46 33.6 (10) Beighton& H. Mar
Schizophrenic & PD
cases: 9 x JHS and
higher positive
symptoms
Bulbena et al.,
2006 [34] D Spain 1305 subjects
45.7 /
54.3 43.4 (18.3) Beighton
JHS cases: higher
scores in fear and
phobia scales
Gülsün et al., 2007
[42] CC Turkey
52 thorax
deformity
40 CTL
Males 21.9 (1.3) Beighton JHS cases: higherscores in HAM-A
Baeza-Velasco
&Bulbena 2009
[43]
D Severalcountries 158 high stature
46.8 /
53.2 25.7 (8.1)
Hakim &
Grahame
JHS cases: higher
scores in LSAS
García-Campayo
et al., 2010 [40] CC Spain
55 PD
55 Psychiatric CTL
55 Fibromyalgia
55 Healthy CTL
Matched Matched Beighton PD cases: 13 x JHS
Pailhez et al.,
2011 [35] D Spain 150 subjects 44 / 56 16.4 (0.6)
Hakim &
Grahame
JHS cases: higher
scores in fear and
phobia scales
Bulbena et al.,
2011 [23] C Spain 137 subjects
53.3 /
46.7 31.9 (2.4)
Beighton
& H. Mar
JHS cases: 22 x PD, 6.5
x SPh and 3.3 x Ph
Table 5. Relationship between JHS and anxiety disorders. Basic features of studies reviewed. D, descriptive study; CC,
case–control study; C, cohort study; E, epidemiological study; CTL, controls; PD, Panic disorder; Aph, Agoraphobia;
MVP, Mitral valve prolapse; SCHZ, Schizophrenia; SPh, Social phobia; Ph, Specific phobia. Sex expressed in percentage
(%) male/female. Age expressed in mean (SD).
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5. Weather, medical conditions and panic attacks
The relationship between meteorological variables and human behaviour has been subject of
conjecture since Hippocrates. This interaction has been held more in popular belief than in sci‐
entific verification. However, since mid 1900s it has been more thoroughly studied, and we are
now in a better position to test popular beliefs regarding this connection. Numerous studies in
different fields have been carried out in an attempt to assess this relationship and its implica‐
tions. Studies about meteorological variables and stroke onset [44], myocardial infarction [45]
and arthritic pain [46] have shown significant results. Moreover, subjective experience from pa‐
tients, such as variations in pain thresholds and mood swings when the weather changes, points
towards this association and paves the road towards further research.
There are few studies designed to specifically assess the association between meteorological
variables and clearly defined psychiatric disorders. Our group has studied this relationship
with anxiety disorders [47]. Anxiety disorders are a clinically heterogeneous group that should
be evaluated by differentiating panic and non-panic anxiety states due to the different clinical
features present in each. Panic disorder has been associated with JHS, which is not seen in gener‐
alized anxiety disorder. Due to this association, the physical variables tend to be more relevant.
This evidence has partly motivated the need to assess the association of meteorological varia‐
bles with anxiety disorders and panic attacks separately and specifically.
All psychiatric emergencies attended at a general hospital in Barcelona (Spain) during 2002
with anxiety as main complaint were classified as panic or non-panic anxiety according to
strict independent and retrospective criteria. Both groups were assessed and compared with
meteorological data (wind speed and direction, daily rainfall, temperature, humidity and so‐
lar radiation). Seasons and weekend days were also included as independent variables. Epi‐
sodes of panic were three times more common with the poniente wind (hot wind), twice less
often with rainfall, and one and a half times more common in autumn than in other seasons
(table 6). These three trends (hot wind, rainfall, and autumn) were accumulative for panic
episodes in a logistic regression formula. Significant reduction of episodes on weekends was
found only for non-panic episodes. Panic attacks, unlike other anxiety episodes, in a psychi‐
atric emergency department in Barcelona seem to show significant meteorotropism.
Any Anxiety Days Panic Anxiety Days Non-panic Anxiety Days
Variables OR (95%CI) OR (95%CI) OR (95%CI)
Poniente Wind 1.23 0.66 2.36 3.32 1.76 6.34 0.60 0.30 1.15
Saturday-Sunday 0.69 0.43 1.09 0.92 0.55 1.52 0.55 0.34 0.89
Autumn 1.63 0.99 2.72 1.67 1.00 2.77 1.40 0.86 2.27
Rain 0.78 0.49 1.26 0.55 0.31 0.93 0.94 0.58 1.51
Whole Model p 0.11 0.0003 0.035
Table 6. Odds ratio for days with anxiety (all, panic and non panic), through logistic regression models [47].
Co-Morbid Anxiety and Physical Disorders: a Possible Common Link with Joint Hypermobility Syndrome
http://dx.doi.org/10.5772/51892
225
On the whole, the results show a higher meteorological sensitivity in patients suffering from
panic disorder. In these patients, warm wind increases the risk by three, rain onset reduces
it to one-half, and autumn increases it by one and a half. This is not observed in non-panic
anxiety, where meteorological effects were not found to be significant.
6. Perspectives
There is enough evidence showing that comorbidity of anxiety disorders and some medical
conditions share a similar physiopathological mechanism mediated by the clinical features
of JHS. Having arrived at this point, it might be relevant to remind the high association of
JHS and the so called dysautonomia. In this way, significant research by Gazit and collea‐
gues [48] found that symptoms related to anxiety such as palpitations, light-headedness,
nausea, shortness of breath, hyperventilation, tremulousness, chest discomfort, fatigue, etc.,
were significantly more common among patients with JHS. Moreover, they found that or‐
thostatic hypotension, postural orthostatic tachycardia syndrome and uncategorized ortho‐
static intolerance were present in 78% of the studied patients with JHS compared to 10% of
control subjects. Thus, they suggested that dysautonomia could be an extra-articular related
feature of JHS. It is plausible that the autonomic nervous system of patients with JHS might
be overeactive to some environmental stimuli like the weather.
However, under the “modern” name dysautonomia not only anxiety features can be found
[49] but also many symptoms described for more than two centuries in the present group of
anxiety disorders [50]. Anxiety manifestations are among the most difficult to identify in the
clinical practice even in patients suffering from generalized anxiety disorder, in which only
13% present anxiety as main complaint. Although dysautonomia and anxiety disorders are
not in the same spectrum, they probably overlap.
In this sense, Eccles et al. have studied associations between regional cerebral grey matter
and hypermobility in healthy volunteers. They found that bilateral amygdala volume distin‐
guished those with hypermobility from those without it. Their data implicate the amygdala
as a likely neural substrate mediating previously reported clinical associations between hy‐
permobility, anxiety and psychosomatic conditions. Anxiety is linked theoretically to the ab‐
normal generation and mapping of bodily arousal through the engagement of amygdala
and insula. Enhanced interoceptive sensitivity also points to a more finely tuned sensory
representation of internal bodily signals within the hypermobile group. Finally, they suggest
that hypermobility is a multisystem phenotype that could mediate clinical vulnerability to
neuropsychiatric symptoms [51]. Therefore, the link between JHS and dysautonomia pro‐
vides an interesting physiological connection to interpret this unexpected association be‐
tween a “somatic” and a “psychiatric” condition.
Our results  address  the biological  basis  of  anxiety and a  common source of  this  condi‐
tion with other constitutional disturbances in relation to connective tissue and the auto‐
nomic  nervous  system.  Patients  with  a  diagnosis  of  JHS  provide  a  highly  valuable
opportunity  for  an in-depth study of  the  genetic  basis  of  anxiety.  Anxiety  is  also  a  co‐
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morbidity and a risk factor in itself  for a poor prognosis in several psychiatric diseases,
as is the case with schizophrenia and bipolar disorders.  These diseases also provide op‐
portunities to further explore the connection between joint hypermobility and the devel‐
opment of anxiety in these conditions.
It is also important to point out a possible application of this evidence; as patients with JHS
are at greater risk of suffering from anxiety conditions, it would be desirable to prevent the
development of anxiety disorders by means of community programs at the very early stages
of development. We strongly recommend screening for joint hypermobility in routine health
assessment protocols in teenagers and early adulthood subjects. Even though the clinical
evaluation of JHS is not extremely difficult, it does inevitably require formal training and an
external validation of the procedure. In this context, some anamnestic questions might be
useful for detecting positive cases at risk of suffering from anxiety disorders.
7. Conclusions
Finally, several conclusions can be made after more than 30 years of active research and clin‐
ical work in that field.
First, the association between anxiety (clinical and non clinical) and JHS is strong and repli‐
cated in several setting and samples.
Second, both conditions carry high genetic and heritable load. This is clinically very well
established,  but  at  the genetic  level,  there  is  no clear  conclusion yet.  Our finding of  an
interstitial duplication of human chromosome 15 (named DUP 25) as responsible for this
association  (with  a  non-Mendelian  mechanism  of  disease-causing  mutation)  is  now  ac‐
tively revisited.
Third, according to the type and number of somatic conditions found in the otherwise
named “endogenous” anxiety disorders (panic, agoraphobia and social phobia), it seems
that these patients tend to suffer from a particular cluster of disorders, particularly, osteo-
muscular, irritable bowel, hypo/hyperthiroid, migraine, asthma, etc. It might well be that all
these conditions share some common abnormalities in the autonomic nervous system as
well as in the collagen structure as found in JHS. This may be a diathesis not yet identified,
but worthy to investigate.
And fourth,  the  autonomic  disregulation,  although very  difficult  to  assess  at  that  level,
may be one of  the clues to understand the association,  and also to develop appropriate
treatments.
In summary, this intriguing relationship gives rise to several physio-pathological questions
and prevention-related issues. JHS is a risk factor for anxiety disorders, worthy of evidence-
based identification in the context of preventive psychiatry not only among adults but also
among at-risk pediatric populations.
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